SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640455-17-000041
Filing Date
2017-08-09
Accepted
2017-08-09 11:00:11
Documents
56
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q jnce0630201710-q.htm 10-Q 1242569
2 EXHIBIT 31.1 jnce06302017exhibit311.htm EX-31.1 10033
3 EXHIBIT 31.2 jnce06302017exhibit312.htm EX-31.2 10031
4 EXHIBIT 32.1 jnce06302017exhibit321.htm EX-32.1 11728
  Complete submission text file 0001640455-17-000041.txt   5196554

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT jnce-20170630.xml EX-101.INS 912693
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnce-20170630.xsd EX-101.SCH 37616
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jnce-20170630_cal.xml EX-101.CAL 55135
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnce-20170630_def.xml EX-101.DEF 264264
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnce-20170630_lab.xml EX-101.LAB 536677
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnce-20170630_pre.xml EX-101.PRE 333218
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37998 | Film No.: 171016823
SIC: 2836 Biological Products, (No Diagnostic Substances)